Tien Liang BioTech Co., Ltd. (TPEX:4127)
36.00
+0.45 (1.27%)
Mar 27, 2026, 9:02 AM CST
Tien Liang BioTech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 122.31 | 130.67 | 142.22 | 107.84 | 118.47 |
Short-Term Investments | 30 | - | - | - | - |
Cash & Short-Term Investments | 152.31 | 130.67 | 142.22 | 107.84 | 118.47 |
Cash Growth | 16.56% | -8.12% | 31.87% | -8.97% | 2.81% |
Accounts Receivable | 47.02 | 40.89 | 75.04 | 97.05 | 97.84 |
Other Receivables | 0.22 | 0.1 | 0.01 | 0.01 | - |
Receivables | 47.24 | 40.98 | 75.05 | 97.07 | 97.84 |
Inventory | 67.04 | 58.49 | 75.8 | 94.97 | 60.95 |
Prepaid Expenses | 7.1 | 8.82 | 11.15 | 22.48 | 13.4 |
Other Current Assets | 11.42 | 7.58 | 4.83 | 3.92 | 4.22 |
Total Current Assets | 285.11 | 246.54 | 309.04 | 326.27 | 294.89 |
Property, Plant & Equipment | 335.55 | 324.07 | 334.03 | 339.2 | 349.48 |
Long-Term Investments | 536.23 | 296.65 | - | - | - |
Other Intangible Assets | 0.4 | 0.44 | 0.51 | 0.24 | 0.62 |
Long-Term Deferred Tax Assets | 3.65 | 5.36 | 5.6 | 5.89 | 5.79 |
Other Long-Term Assets | 22.29 | 15.62 | 4.86 | 4.82 | 4.58 |
Total Assets | 1,183 | 888.68 | 654.04 | 676.43 | 655.35 |
Accounts Payable | 56.51 | 32.9 | 25.9 | 26.05 | 46.41 |
Accrued Expenses | - | 28.33 | 29.55 | 40.46 | 28.61 |
Short-Term Debt | 598 | 335 | 70 | 100 | 130.5 |
Current Portion of Leases | - | 0.38 | 0.5 | 0.52 | 0.78 |
Current Income Taxes Payable | - | - | 0.73 | - | - |
Other Current Liabilities | 54.38 | 10.78 | 18.17 | 18.49 | 17.86 |
Total Current Liabilities | 708.89 | 407.38 | 144.85 | 185.51 | 224.16 |
Long-Term Leases | - | - | 0.38 | 0.88 | 1.4 |
Pension & Post-Retirement Benefits | - | - | 15.8 | 14.52 | 15.69 |
Long-Term Deferred Tax Liabilities | 0.3 | 3.38 | 0.03 | 0.4 | 0.05 |
Total Liabilities | 709.19 | 410.76 | 161.05 | 201.3 | 241.3 |
Common Stock | 457.6 | 457.6 | 457.6 | 457.6 | 457.6 |
Retained Earnings | 23.24 | 32.93 | 35.38 | 17.53 | -43.55 |
Comprehensive Income & Other | -6.8 | -12.6 | - | - | - |
Shareholders' Equity | 474.04 | 477.92 | 492.98 | 475.13 | 414.05 |
Total Liabilities & Equity | 1,183 | 888.68 | 654.04 | 676.43 | 655.35 |
Total Debt | 598 | 335.38 | 70.88 | 101.4 | 132.67 |
Net Cash (Debt) | -445.69 | -204.71 | 71.34 | 6.44 | -14.21 |
Net Cash Growth | - | - | 1007.04% | - | - |
Net Cash Per Share | -9.57 | -4.47 | 1.56 | 0.14 | -0.31 |
Filing Date Shares Outstanding | 49.1 | 45.76 | 45.76 | 45.76 | 45.76 |
Total Common Shares Outstanding | 49.1 | 45.76 | 45.76 | 45.76 | 45.76 |
Working Capital | -423.77 | -160.84 | 164.19 | 140.76 | 70.73 |
Book Value Per Share | 9.65 | 10.44 | 10.77 | 10.38 | 9.05 |
Tangible Book Value | 473.64 | 477.48 | 492.47 | 474.88 | 413.43 |
Tangible Book Value Per Share | 9.65 | 10.43 | 10.76 | 10.38 | 9.03 |
Land | - | 144.74 | 144.74 | 144.74 | 144.74 |
Buildings | - | 298.32 | 298.05 | 297.83 | 297.83 |
Machinery | - | 87.73 | 103.86 | 99.44 | 99.39 |
Leasehold Improvements | - | - | - | - | 0.27 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.